Pam R. Taub, MD❤️💃🏻
@PamTaubMD
Cardiologist/Professor of Medicine at UC San Diego, Clinician/Scientist, Zumba Lover, Passionate about Prevention
AHA WIC is excited to kick off a new year and welcome new members to our committee. Save the date for our annual Women in Cardiology Luncheon at the AHA meeting in New Orleans on November 8th, 2025, from 1130 AM to 130 PM. We will be presenting the AHA WIC Mentoring Award and…
Great insights from @ProfKausikRay on the Victorian Mono study.
Our editorial of the Victorian Mono trial provides a nuanced understanding of the interplay between diet, LDLR- PCSK9 and circulating LDL-C levels through the Len’s of known knowns, known unknowns and unknown unknowns kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
Join us at RISE @ ESC Congress 2025 for a lunch symposium on women’s heart health. 🎤 Expert panel: Drs. @mirvatalasnag, @KendraGrubb, @PamTaubMD & Joanna Wykrzykowska 📣 A global call to action Register: rise.womenasone.org #LetsRISE2025 #ESCCongress #WCCardio #WIC
Fasting for 14+ hours activates autophagy—your body’s cleanup mechanism
➡️In @LipidJournal: real-world data, early experience with inclisiran @UCSDHealth @UCSDCardiology Congrats @DMazdeyasnan, @AntoinetteBirs, @TommyTChiou @PamTaubMD @ASPCardio @CBallantyneMD @DrMichaelShapir @tmodarressi @ArchnaBajajMD @Nishant_ShahMD sciencedirect.com/science/articl…
We are excited to announce the launch of the UC San Diego BEACON (Bioinformatics, Epidemiology, and Lp(a) Center for Research and InnOvatioN), in the Division of Cardiovascular Medicine: lpa.ucsd.edu We look forward to collaborating with our colleagues across the…
Why should you test for Lp(a)? #KnowLpa @FamilyHeartFdn @ASPCardio @UCSDCardiology @UCSDCardFellows
Lp(a) is genetically determined, pro-atherogenic, and present in ~20% of patients—yet <1% are tested. A one-time test can inform risk stratification and therapeutic intensity. Watch the full clinical review from @hsbhatia now on Vumedi. tinyurl.com/6jycacub #Vumedi…
Happy birthday to the @UCSDCardiology legend of Atrial Flutter ablation and rock and roll, Dr. Feld!
NEW #RCParallax by @AnkurKalraMD Ep 136 🎙️This week's guest is Dr @PamTaubMD who joins for an enlightening conversation about integrating spirituality, purpose, and scientific curiosity in cardiovascular practice. 🎧 Listen Now 👉 ow.ly/rF0n50W6gvh #CardioEd #MedEd
#HID2025 Superb talk by @PamTaubMD at @HeartinDiabetes on lipid management in women across life course. ➡️ Lp(a) rises in menopause. Recheck level if previously borderline. ➡️Bempedoic acid a good option in statin intol. ➡️ Optimize CV risk factors before menopause. @MIOAmerica
Honored to moderate this @Medscape @theheartorg CME with D. Rader & @PamTaubMD on new exciting strategies to improve the lives of pts with familial chylomicronemia syndrome medscape.org/viewarticle/da…
Finerenone reduces CKD progression & CVD in T2D (FIDELIO/FIGARO), driven by ↓ HF hospitalizations. FINEARTS-HF shows benefit in HFmrEF/HFpEF. More to come from MOONRAKER in HF irrespective of EF (link.springer.com/article/10.100…). #HREV @PamTaubMD @SJGreene_md @FudimMarat @AndrewJSauer
Congrats to my mentee @CameronOrmiston who has been working with me since he was a freshman at @UCSD and is now a medical student at @MountSinaiNYC for leading this article. We showed in this proof-of-concept study that pure epicatechin capsules (epicatechin is present in…
JACC STATE-OF-THE-ART REVIEW: do you have problems understanding all the new drugs to lower triglycerides and remnant cholesterol: lipid and side effects, target populations, approved or not by FDA+EMA? Ask Tybjærg Nordestgaard et al explain the details authors.elsevier.com/a/1l4pB2d9GI27…
For those not able to join us but who are interested in the presentation, it is available to view here: lipid.org/practicalpearls
Could not agree more @ProfKausikRay ! ❤️@EASCongress @BNordestgaard @PamTaubMD @SABOURETCardio @rohan_khera @CBallantyneMD @drpablocorral @FedericaFogacci @pabeda1 @DrMichaelShapir @DrMarthaGulati @JohnKastelein @MeralKayikcoglu @Marta33717088 #EASCongress2025
#EASCongress2025 Late Breakers - Key takeaway in one line! #MyEAS2025 Check out the slide below for a one-line summary of each late-breaking presentation — concise, clear, and all in one place 😎 @EASCongress @society_eas
@PamTaubMD excellent presentation on role of Inclisiran monotherpy. @JACCJournals @BNordestgaard @ProfKausikRay @EASCongress #EAS2025
Great overview by @CBallantyneMD at the joint @nationallipid @society_eas session.@ProfKausikRay @BNordestgaard @JamalRanaMD @pabeda1 @DrMarthaGulati @rauldsf_santos @drpablocorral
@BNordestgaard giving an outstanding talk at the joint @society_eas and @nla at #EAS2025 on remnant cholesterol. @CBallantyneMD @DrMarthaGulati @tmodarressi @JamalRanaMD @pabeda1 @ProfKausikRay
